A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the safety and efficacy of rusfertide in subjects with
polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.